Yoji Andrew Minamishima (Yoji A Minamishima)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 5

Top Topics

Editorial Comment

Acinetobacter Baumannii

Antibiotic Resistance Genes

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Microbiology spectrum

Molecular and cellular biology

Gunma University

Kyushu University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gunma University Dec 01 2018

Japan

Professor :: Biochemistry

Kyushu University Apr 01 2016 - Nov 30 2018

Japan

Associate Professor :: Medical Institute of Bioregulation

Keio University Sep 01 2010 - Mar 31 2015

Japan

Assistant Professor :: Biochemistry

Japan Science and Technology Agency Sep 01 2010 - Mar 31 2015

Japan

Group Leader :: ERATO, Suematsu Gas Biology Project

Howard Hughes Medical Institute Sep 13 2004 - Aug 19 2010

United States

Research fellow

Dana-Farber Cancer Institute Sep 13 2004 - Aug 19 2010

United States

Post doctoral research fellow :: Medical Oncology

Harvard Medical School Apr 08 2002 - Aug 19 2010

United States

Post doctoral research fellow

Beth Israel Deaconess Medical Center Apr 08 2002 - Sep 13 2004

United States

Post doctoral research fellow :: Geriatrics

Education History

Kyushu University Apr 01 1998 - Mar 31 2002

Japan

PHD :: Medical Institute for Bioregulation

Publications

Hidetada Hirakawa, Ayako Takita, Yumika Sato, Suguru Hiramoto, Yusuke Hashimoto, Noriyasu Ohshima, Yoji Andrew Minamishima, Masami Murakami, Yoshiharu Tomita
Inactivation of ackA and pta Genes Reduces GlpT Expression and Susceptibility to Fosfomycin in Escherichia coli . Microbiology spectrum (2023)
Hajime Takamori, Toshinari Yamasaki, Rui Kitadai, Yoji Andrew Minamishima, Eijiro Nakamura
The development of drugs targeting HIF against tumor cells with VHL mutation: the story of 127 years. Cancer science (2023)
Hajime Takamori, Toshinari Yamasaki, Rui Kitadai, Yoji Andrew Minamishima, Eijiro Nakamura
Development of drugs targeting hypoxia-inducible factor against tumor cells with VHL mutation: Story of 127 years. Cancer science (2023)
Tomoko Oyaizu-Toramaru, Tomohiro Suhara, Noriyo Hayakawa, Takashi Nakamura, Akiko Kubo, Shizuka Minamishima, Kyoji Yamaguchi, Takako Hishiki, Hiroshi Morisaki, Makoto Suematsu, Yoji Andrew Minamishima
Targeting Oxygen-Sensing Prolyl Hydroxylase for Metformin-Associated Lactic Acidosis Treatment. Molecular and cellular biology 37 (16) (2017)
Tomohiro Suhara, Takako Hishiki, Masataka Kasahara, Noriyo Hayakawa, Tomoko Oyaizu, Tsuyoshi Nakanishi, Akiko Kubo, Hiroshi Morisaki, William G Kaelin, Makoto Suematsu, Yoji Andrew Minamishima
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle. Proceedings of the National Academy of Sciences of the United States of America 112 (37) (2015)